HAVN Life To Be Featured On Viewpoint with Dennis Quaid Post published:June 22, 2022 Post category:Press Release
Algernon Pharmaceuticals Announces Issuance of Patent for Ifenprodil for the Treatment of Idiopathic Pulmonary Fibrosis Post published:June 22, 2022 Post category:Press Release
Mindset Pharma and Top Psychiatric Research Hospital, CAMH, Enter Innovative Collaboration to Build Molecular Profile of MSP-1014 Compared to Psilocybin Post published:June 22, 2022 Post category:Press Release
Small Pharma to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022 Post published:June 22, 2022 Post category:Press Release
Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2022 Results Conference Call for Thursday, June 30, 2022 at 8:30 AM ET Post published:June 22, 2022 Post category:Press Release
Yale’s Department of Psychiatry Chair to Join Clearmind Medicine Post published:June 21, 2022 Post category:Press Release
Optimi Health Requests Approval To Manufacture MDMA, Other Synthetic Psychedelics Post published:June 20, 2022 Post category:Press Release
Psychedelic Bulletin #107 – Call for Proposals: Opinions Column; How to Change Your Mind Comes to Netflix Post published:June 18, 2022 Post category:Psychedelic Bulletin
Stephen Bardin to Join atai Life Sciences as CFO Designate Post published:June 17, 2022 Post category:Press Release
Bexson Biomedical to present at the H.C. Wainwright and Beryl Elites Conferences Post published:June 17, 2022 Post category:Press Release